NCT01380431

A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study

Randomized, Open-label, Three Treatment Crossover Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: Par Pharmaceutical, Inc. · Industry
• Sex: Male
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare the bioavailability of Par Lisinopril 40 mg Tablets and IPR Pharmaceuticals, Inc. Zestril (R).

Detailed description

To compare the bioavailability of Par Lisinopril 40 mg Tablets and IPR Pharmaceuticals, Inc. Zestril (R), 40 mg - Effect of Food Study

Conditions

• To Determine Bioequivalence Under Fed Conditions

Interventions

Type	Name	Description
DRUG	Lisinopril	Tablets, 40 mg, single oral dose
DRUG	lisinopril	Tablets, 40 mg, single, oral dose
DRUG	Lisinopril	50% of subjects received the Par formulated product.

Timeline

• Start date: 1999-08-01
• Primary completion: 1999-10-01
• Completion: 1999-10-01
• First posted: 2011-06-27
• Last updated: 2011-06-27

Locations

1 site across 1 country: United States